LIZOPRIL

This brand name is authorized in Nigeria.

Active ingredients

The drug LIZOPRIL contains one active pharmaceutical ingredient (API):

1	Lisinopril UNII E7199S1YWR - LISINOPRIL
	Lisinopril is a peptidyl dipeptidase inhibitor. It inhibits the angiotensin-converting enzyme (ACE) that catalyses the conversion of angiotensin I to the vasoconstrictor peptide, angiotensin II. Angiotensin II also stimulates aldosterone secretion by the adrenal cortex. Inhibition of ACE results in decreased concentrations of angiotensin II which results in decreased vasopressor activity and reduced aldosterone secretion.
	Read more about Lisinopril

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-2467	Tablet	Lizopril 10 TAB 10 mg 2 x 14's (in PVC-Alu blisters)	Tablet	27/06/2024
A4-2468	Tablet	Lizopril 5_ TAB 5 mg 2 x 14's in Alu PVC Blisters	Uncoated Tablets. 12 RNW-PP-417216 LIZOPRIL 5 LISINOPRIL DIHYDRATE EQ. TO LISINOPRIL 5MG Lisinopril Dihydrate Eq. To Lisinopril 5mg,Maize starch, Microcrystalline cellulose, Povidone, Magnesium Stearate, Purified Talc, Sodium Starch Glycolate, Colloidal Anhydrous Silica. A4-2468 Drugs Imported Products 2X14 Prescription Only Medicine (POM) 4/17/2024 SAM PHARMACEUTICALS LIMITED, OYADIRAN ESTATE, SABO YABA SABO YABA LAGOS 17753455 sampharm18@yahoo.com SWISS PHARMA PVT. LTD INDIA, 3709 G.T.D.C PHASE IV VATVA, AHMEDABAD-382445, India	27/06/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C09AA03	Lisinopril	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09A ACE inhibitors, plain → C09AA ACE inhibitors, plain
Discover more medicines within C09AA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-2467, A4-2468